Puberty
19
10
11
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 19 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (19)
Investigating the Impact of Obesity on Pubertal Development in Girls
Rejection Sensitivity and Puberty in Mental Health Vulnerability to Social Media Experiences in Early Adolescent Girls
Minipuberty of Infancy and the Timing of Pubertal Development in Adolescence: a Follow-up of the Infant Feeding and Early Development (IFED) Cohort
ActiveGirls: Physical Activity, Hormone Health, and Diabetes Risk in Early Adolescence
Improving Health Among Disadvantaged Girls to Slow Pubertal Onset and Reduce Long-term Health Risks
Spexin and Phoenixin-20 in Girls With Central Precocious Puberty
Skeletal Health and Bone Marrow Composition Among Youth
Does Spironolactone Normalize Sleep-wake Luteinizing Hormone Pulse Frequency in Pubertal Girls With Hyperandrogenism?
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
Negative Emotionality and Epigenetics During Puberty
Ovarian Morphology in Girls
Association of Acne Vulgaris With Oral Hygiene and Gingivitis
The 3rd COPENHAGEN Puberty Study
Assessment of Day-night Secretion of Progesterone and LH Across Puberty
Urinary DENND1A.V2 as a Predictor of Pubertal Hyperandrogenemia
Diet and Nutrition Pilot Study for Chinese Adolescents and Their Mothers
The COPENHAGEN Puberty Study